Stamford, CT -- (SBWIRE) -- 10/24/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: ScripsAmerica, Inc. (OTCBB:SCRC), Titan Pharmaceuticals, Inc. (OTCBB:TTNP), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), AMERICAN COMMUNITY (OTCMKTS:ACYD)
ScripsAmerica, Inc. (OTCBB:SCRC) experienced an upsurge of +24.28%, to a market valuation of $17.87 million per share for the previous trading session. After opening the day at $0.25 per share, volume surged to 669,248, moving forward from its daily average volume of 209,071 shares. The stock remained in the $0.25 to $0.33 price range during the session. ScripsAmerica, Inc. engages in the distribution of pharmaceutical products in the United States. It delivers pharmaceutical products, including pain, arthritis, prenatal, urinary, and hormonal replacement drugs to a range of customers across the health care industry, including physician offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies.
For How Long SCRC’s Gloss will Attract Investors? Find out via this report
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) opened its shares at the price of $0.81 for the day, its closing price was $0.920 after gaining +9.52% for the day. The company traded with the total volume of 445,592 million shares, while its average trading volume remained 1.01 million shares. The beta of TTNP stands at 9.68.
If we review the company’s graph to check its previous trends, we come to know these figures: During the last 5 trades the stock plummeted almost -8%. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
For How Long TTNP will fight for Profitability? Read This Trend Analysis report
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) percentage change reduced -5.88%, to close at $0.800 with the total traded volume of 913,618 shares, more than average volume of 722,104.
Company’s year to date performance remained optimistic with the rise of +44.64%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of +22.73%. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications
Why Should Investors Buy PVCT After the Recent Fall? Just Go Here and Find Out
AMERICAN COMMUNITY (OTCMKTS:ACYD) remained among the day gainers and traded with volume of 5.42 million shares in the last session, as compared to average volume of 17.81 million shares.
Its day's lowest price was $0.04 and its hit its day's highest price at $0.04. ACYD’s total market capitalization is $98.80 million. WIALAN Technologies, LLC operates as a software and hardware integrator that manufactures industrial grade wireless equipment to enable the deployment of IP base services.
Why Should Investors Buy ACYD After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)